189 related articles for article (PubMed ID: 26899863)
1. Transportan 10 improves the anticancer activity of cisplatin.
Izabela R; Jarosław R; Magdalena A; Piotr R; Ivan K
Naunyn Schmiedebergs Arch Pharmacol; 2016 May; 389(5):485-97. PubMed ID: 26899863
[TBL] [Abstract][Full Text] [Related]
2. Protein and siRNA delivery by transportan and transportan 10 into colorectal cancer cell lines.
Wierzbicki PM; Kogut-Wierzbicka M; Ruczynski J; Siedlecka-Kroplewska K; Kaszubowska L; Rybarczyk A; Alenowicz M; Rekowski P; Kmiec Z
Folia Histochem Cytobiol; 2014; 52(4):270-80. PubMed ID: 25511292
[TBL] [Abstract][Full Text] [Related]
3. Dual-Activity Fluoroquinolone-Transportan 10 Conjugates Offer Alternative Leukemia Therapy during Hematopoietic Cell Transplantation.
Lica JJ; Heldt M; Wieczór M; Chodnicki P; Ptaszyńska N; Maciejewska N; Łęgowska A; Brankiewicz W; Gucwa K; Stupak A; Pradhan B; Gitlin-Domagalska A; Dębowski D; Milewski S; Bieniaszewska M; Grabe GJ; Hellmann A; Rolka K
Mol Pharmacol; 2023 Dec; 105(1):39-53. PubMed ID: 37977824
[TBL] [Abstract][Full Text] [Related]
4. Continuous detection of entry of cell-penetrating peptide transportan 10 into single vesicles.
Moghal MMR; Islam MZ; Sharmin S; Levadnyy V; Moniruzzaman M; Yamazaki M
Chem Phys Lipids; 2018 May; 212():120-129. PubMed ID: 29425855
[TBL] [Abstract][Full Text] [Related]
5. Role of Membrane Potential on Entry of Cell-Penetrating Peptide Transportan 10 into Single Vesicles.
Moghal MMR; Islam MZ; Hossain F; Saha SK; Yamazaki M
Biophys J; 2020 Jan; 118(1):57-69. PubMed ID: 31810658
[TBL] [Abstract][Full Text] [Related]
6. Cell surface clustering of heparan sulfate proteoglycans by amphipathic cell-penetrating peptides does not contribute to uptake.
Verdurmen WP; Wallbrecher R; Schmidt S; Eilander J; Bovee-Geurts P; Fanghänel S; Bürck J; Wadhwani P; Ulrich AS; Brock R
J Control Release; 2013 Aug; 170(1):83-91. PubMed ID: 23669260
[TBL] [Abstract][Full Text] [Related]
7. Entry of cell-penetrating peptide transportan 10 into a single vesicle by translocating across lipid membrane and its induced pores.
Islam MZ; Ariyama H; Alam JM; Yamazaki M
Biochemistry; 2014 Jan; 53(2):386-96. PubMed ID: 24397335
[TBL] [Abstract][Full Text] [Related]
8. Conjugates of Ciprofloxacin and Levofloxacin with Cell-Penetrating Peptide Exhibit Antifungal Activity and Mammalian Cytotoxicity.
Ptaszyńska N; Gucwa K; Olkiewicz K; Heldt M; Serocki M; Stupak A; Martynow D; Dębowski D; Gitlin-Domagalska A; Lica J; Łęgowska A; Milewski S; Rolka K
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32630159
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of transportan 10 in PEI mediated plasmid delivery assay.
Kilk K; El-Andaloussi S; Järver P; Meikas A; Valkna A; Bartfai T; Kogerman P; Metsis M; Langel U
J Control Release; 2005 Mar; 103(2):511-23. PubMed ID: 15763630
[TBL] [Abstract][Full Text] [Related]
10. Irinotecan-cisplatin interactions assessed in cell-based screening assays: cytotoxicity, drug accumulation and DNA adduct formation in an NSCLC cell line.
Zastre J; Anantha M; Ramsay E; Bally M
Cancer Chemother Pharmacol; 2007 Jun; 60(1):91-102. PubMed ID: 17009029
[TBL] [Abstract][Full Text] [Related]
11. LXXLL peptide converts transportan 10 to a potent inducer of apoptosis in breast cancer cells.
Tints K; Prink M; Neuman T; Palm K
Int J Mol Sci; 2014 Apr; 15(4):5680-98. PubMed ID: 24705462
[TBL] [Abstract][Full Text] [Related]
12. Identification of cell-penetrating peptides that are bactericidal to Neisseria meningitidis and prevent inflammatory responses upon infection.
Eriksson OS; Geörg M; Sjölinder H; Sillard R; Lindberg S; Langel U; Jonsson AB
Antimicrob Agents Chemother; 2013 Aug; 57(8):3704-12. PubMed ID: 23689723
[TBL] [Abstract][Full Text] [Related]
13. Transportan 10 improves the pharmacokinetics and pharmacodynamics of vancomycin.
Ruczyński J; Rusiecka I; Turecka K; Kozłowska A; Alenowicz M; Gągało I; Kawiak A; Rekowski P; Waleron K; Kocić I
Sci Rep; 2019 Mar; 9(1):3247. PubMed ID: 30824786
[TBL] [Abstract][Full Text] [Related]
14. Design of acid-activated cell penetrating peptide for delivery of active molecules into cancer cells.
Zhang W; Song J; Zhang B; Liu L; Wang K; Wang R
Bioconjug Chem; 2011 Jul; 22(7):1410-5. PubMed ID: 21663318
[TBL] [Abstract][Full Text] [Related]
15. Cell penetrating peptides fail to induce an innate immune response in epithelial cells in vitro: implications for continued therapeutic use.
Carter E; Lau CY; Tosh D; Ward SG; Mrsny RJ
Eur J Pharm Biopharm; 2013 Sep; 85(1):12-9. PubMed ID: 23958314
[TBL] [Abstract][Full Text] [Related]
16. Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway.
Wang R; Ma L; Weng D; Yao J; Liu X; Jin F
Oncol Rep; 2016 May; 35(5):3075-83. PubMed ID: 26987028
[TBL] [Abstract][Full Text] [Related]
17. Cellular uptake of transportan 10 and its analogs in live cells: Selectivity and structure-activity relationship studies.
Song J; Kai M; Zhang W; Zhang J; Liu L; Zhang B; Liu X; Wang R
Peptides; 2011 Sep; 32(9):1934-41. PubMed ID: 21827806
[TBL] [Abstract][Full Text] [Related]
18. Influence of stearyl and trifluoromethylquinoline modifications of the cell penetrating peptide TP10 on its interaction with a lipid membrane.
Anko M; Majhenc J; Kogej K; Sillard R; Langel U; Anderluh G; Zorko M
Biochim Biophys Acta; 2012 Mar; 1818(3):915-24. PubMed ID: 22240008
[TBL] [Abstract][Full Text] [Related]
19. Detection of the Entry of Nonlabeled Transportan 10 into Single Vesicles.
Shuma ML; Moghal MMR; Yamazaki M
Biochemistry; 2020 May; 59(18):1780-1790. PubMed ID: 32285663
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activities and action mechanism studies of transportan 10 and its analogues against multidrug-resistant bacteria.
Xie J; Gou Y; Zhao Q; Li S; Zhang W; Song J; Mou L; Li J; Wang K; Zhang B; Yang W; Wang R
J Pept Sci; 2015 Jul; 21(7):599-607. PubMed ID: 25891396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
